The size of the radiotherapy market in Middle-East Africa was worth USD 0.58 billion in 2022 and is estimated to be growing at a CAGR of 5.8% to reach USD 0.77 Billion by 2027.
Radiation therapy is considered a critical cancer treatment and an alternative type of treatment. Radiation therapy is also used to contract tumors and decrease pressure, pain, and other cancer symptoms. In addition, this therapy may be healing in several different types of cancer if they are confined to one area of the body.
An increasing number of cancer patients and fast varying cancer treatment technologies with recurrent invention are driving the market growth. Additionally, improvement of cancer treatment and inclination towards non-invasive procedures of treatment are augmenting the market growth.
The absence of qualified workers to present radiotherapy and competent alternate treatment obstructs the market's growth.
This research report on the Middle East and Africa Radiotherapy market has been segmented and sub-segmented into the following categories:
By Equipment Type:
Regionally, the African radiotherapy market is leading this region, while the Middle East is estimated to witness the highest growth rate in the coming years.
KEY MARKET PLAYERS:
Companies playing an active role in the MEA radiotherapy market profiled in this report are Nordion Inc., RaySearch Laboratories AB, Ion Beam Applications SA, C. R. Bard Inc., Mevion Medical Systems Inc., Varian Medical Systems Inc., IsoRay Medical Inc., Elekta AB, Accuray Incorporated and Mitsubishi Electric Corporation.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org